Why People Are Injecting These Unapproved Drugs From the Internet | WSJ

Key Concepts

• Peptides: Short chains of amino acids that act as signaling molecules in the body; synthetic versions are being used for aesthetic and performance-enhancing purposes.
• Gray Market: An unregulated supply chain where substances labeled "for research use only" are sold to consumers for human use without prescriptions or medical oversight.
• GLP-1 (Glucagon-like peptide-1): A naturally occurring hormone that regulates appetite; the basis for FDA-approved weight-loss medications like Ozempic.
• MT2 (Melanotan II): A synthetic peptide used for tanning that increases melanin production but carries potential risks, including skin changes and melanoma.
• "Stacking": The practice of combining multiple different peptides into a single regimen or vial to achieve synergistic effects.

---

1. The Rise of Peptide Popularity

Peptides have transitioned from niche scientific interest to a mainstream trend, with users ranging from teenagers to senior citizens. The primary drivers for this surge are aesthetic and performance-based goals, including:

• Muscle growth: Enhancing physical performance and hypertrophy.
• Skin health: Achieving clearer, more youthful skin.
• Hair growth: Promoting longer and thicker hair.
• Weight management: Inspired by the success of FDA-approved GLP-1 agonists like Ozempic.

2. The "Research Use Only" Gray Market

A significant portion of the peptide market operates in a legal and safety "gray area."

• Labeling: Products are frequently sold as "for research use only" to bypass FDA regulations regarding human consumption.
• Lack of Oversight: Because these substances are not FDA-approved for the specific uses consumers are pursuing, there is no standardized regulation regarding their safety, efficacy, dosing, or manufacturing sterility.
• The Trust System: Consumers rely on anecdotal evidence from social media influencers and online forums to determine sources and dosages. This creates a high-risk environment where users are essentially "guinea pigs" for substances with limited clinical data.

3. Risks and Health Implications

The lack of clinical trials for many of these synthetic peptides means that long-term side effects are largely unknown.

• Case Study: MT2 (Melanotan II): While effective at increasing melanin for tanning, it is linked to the growth of moles and potential increases in the risk of melanoma.
• Manufacturing Hazards: Since these products are not produced under strict pharmaceutical standards, there is a high risk of contamination, incorrect dosing, or the presence of undisclosed substances within a single vial.
• Stacking Dangers: Users often "cobble together" their own stacks, combining multiple peptides without understanding potential drug-to-drug interactions or cumulative toxicity.

4. Regulatory Landscape and Future Outlook

The FDA is currently navigating the complexities of peptide regulation.

• July Advisory Panel: The FDA is scheduled to meet to discuss whether to re-classify or increase the accessibility of approximately 14 peptides that were restricted in 2023.
• The Pro-Accessibility Argument: Advocates argue that by making certain peptides more accessible through regulated channels, the government could effectively shrink the dangerous gray market. This would ensure that products are manufactured in facilities monitored for sterility and quality control.
• The Counter-Argument: Critics maintain that even if some peptides become more accessible, they remain significantly less studied than standard FDA-approved medications, meaning the risk-to-benefit ratio remains unfavorable for the average consumer.

5. Synthesis and Conclusion

The current trend of self-administering peptides represents a significant public health concern driven by social media influence and the desire for "quick-fix" aesthetic results. While peptides are legitimate biological tools—as evidenced by FDA-approved GLP-1 drugs—the current consumer practice of purchasing unverified substances from the gray market is fraught with danger. Until these substances undergo rigorous clinical trials and receive formal regulatory approval, users are operating without a safety net, risking unknown long-term health consequences for short-term aesthetic gains.